We must try harder to avoid biological bias in clinical trials
27 June 2018
Entry requirements for trials are stacked against certain groups, so the results don't apply to everyone. We need to make things more inclusive
-
Subject
-
Section
-
Type
-
Topics
-
Author
-
Issue
-
Premium
A whole new type of cancer therapy helps treat liver cancer
4 June 2018
By making a gene in the liver work harder, a completely new type of drug has shown promise for treating cases of advanced liver cancer in a small trial
Miniature personalised tumours could help you get the best chemo
22 February 2018
Growing mini tumours in the lab from a patient’s own cells could help doctors discover the best way to treat each person, homing in on the right drugs to use
Calm down – China is not racing ahead with human CRISPR trials
25 January 2018
Despite treating 86 people since 2015, China's approach to CRISPR genome-editing in humans is basic and risky
NHS is switching to cheaper mimics of expensive cancer drugs
3 January 2018
Biological drugs like some antibodies used to fight cancer are difficult to make. The NHS is now turning to cheaper alternatives, but some doctors fear they won’t work as well
Tumour bacteria sabotage chemotherapy by destroying cancer drugs
14 September 2017
Giving antibiotics to people with cancer could improve treatment by stopping bacteria from degrading anticancer drugs
Pioneering gene therapy approved for leukaemia in the US
1 September 2017
CAR-T treatments fight cancer by genetically modifying a person’s own immune cells. A CAR-T therapy has now been approved by the FDA – but it costs $475,000
Tumour-tracking drug that kills cancer approved in the US
31 May 2017
For the first time, a drug that can find and fight cancer – regardless of where it is in the body – has been approved
Cancer drug resurfaces and threatens false optimism
16 May 2011
News of a new cancer drug is creating a frenzy on the internet. The only problem is: it's not new.
